Division of Hematology and Oncology

Research Output 1990 2019

Filter
Comment/debate
2018

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J. & Kelly, K., Aug 17 2018, In : Oncotarget. 9, 64, p. 32403 1 p.

Research output: Contribution to journalComment/debate

Bone Neoplasms
Protein-Tyrosine Kinases
Prostatic Neoplasms
Medicine
Neoplasm Metastasis
2017
Luteolin
uterine cervical neoplasms
luteolin
Quercetin
Flavonoids
2016
decitabine
Azacitidine
Drug Discovery
Genomics
Medicine